128 related articles for article (PubMed ID: 14500389)
1. Selective antimetastatic activity of cytosine analog CS-682 in a red fluorescent protein orthotopic model of pancreatic cancer.
Katz MH; Bouvet M; Takimoto S; Spivack D; Moossa AR; Hoffman RM
Cancer Res; 2003 Sep; 63(17):5521-5. PubMed ID: 14500389
[TBL] [Abstract][Full Text] [Related]
2. [Establishment of red fluorescent protein orthotopic transplantation nude mice metastasis model of pancreatic cancer and whole-body fluorescent imaging].
Yu ZQ; Zhou JH; Tao KT; Hu L; Zheng J; Yang DT
Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(14):1092-5. PubMed ID: 19781277
[TBL] [Abstract][Full Text] [Related]
3. Real-time whole-body imaging of an orthotopic metastatic prostate cancer model expressing red fluorescent protein.
Yang M; Jiang P; Yamamoto N; Li L; Geller J; Moossa AR; Hoffman RM
Prostate; 2005 Mar; 62(4):374-9. PubMed ID: 15389802
[TBL] [Abstract][Full Text] [Related]
4. Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model.
Bouvet M; Wang J; Nardin SR; Nassirpour R; Yang M; Baranov E; Jiang P; Moossa AR; Hoffman RM
Cancer Res; 2002 Mar; 62(5):1534-40. PubMed ID: 11888932
[TBL] [Abstract][Full Text] [Related]
5. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy.
Hoffman RM
Methods Mol Med; 2005; 111():297-322. PubMed ID: 15911987
[TBL] [Abstract][Full Text] [Related]
6. Common bile duct injection as a novel method for establishing red fluorescent protein (RFP)-expressing human pancreatic cancer in nude mice.
Tsuji K; Yang M; Jiang P; Maitra A; Kaushal S; Yamauchi K; Katz MH; Moossa AR; Hoffman RM; Bouvet M
JOP; 2006 Mar; 7(2):193-9. PubMed ID: 16525203
[TBL] [Abstract][Full Text] [Related]
7. Lentivirus-based DsRed-2-transfected pancreatic cancer cells for deep in vivo imaging of metastatic disease.
Zhou J; Yu Z; Zhao S; Hu L; Zheng J; Yang D; Bouvet M; Hoffman RM
J Surg Res; 2009 Nov; 157(1):63-70. PubMed ID: 19589544
[TBL] [Abstract][Full Text] [Related]
8. In vivo imaging of pancreatic cancer with fluorescent proteins in mouse models.
Bouvet M; Hoffman RM
Methods Mol Biol; 2012; 872():51-67. PubMed ID: 22700403
[TBL] [Abstract][Full Text] [Related]
9. An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer.
Katz MH; Takimoto S; Spivack D; Moossa AR; Hoffman RM; Bouvet M
Clin Exp Metastasis; 2004; 21(1):7-12. PubMed ID: 15065597
[TBL] [Abstract][Full Text] [Related]
10. A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics.
Katz MH; Takimoto S; Spivack D; Moossa AR; Hoffman RM; Bouvet M
J Surg Res; 2003 Jul; 113(1):151-60. PubMed ID: 12943825
[TBL] [Abstract][Full Text] [Related]
11. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer.
Kizaka-Kondoh S; Itasaka S; Zeng L; Tanaka S; Zhao T; Takahashi Y; Shibuya K; Hirota K; Semenza GL; Hiraoka M
Clin Cancer Res; 2009 May; 15(10):3433-41. PubMed ID: 19417024
[TBL] [Abstract][Full Text] [Related]
12. Antimetastatic efficacy of oral 5-FU imaged by green fluorescent protein in real time.
Wang JW; Yang M; Wang X; Sun FX; Li XM; Yagi S; Hoffman RM
Anticancer Res; 2003; 23(1A):1-6. PubMed ID: 12680187
[TBL] [Abstract][Full Text] [Related]
13. Survival efficacy of adjuvant cytosine-analogue CS-682 in a fluorescent orthotopic model of human pancreatic cancer.
Katz MH; Bouvet M; Takimoto S; Spivack D; Moossa AR; Hoffman RM
Cancer Res; 2004 Mar; 64(5):1828-33. PubMed ID: 14996746
[TBL] [Abstract][Full Text] [Related]
14. Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice.
Hosotani R; Miyamoto Y; Fujimoto K; Doi R; Otaka A; Fujii N; Imamura M
Clin Cancer Res; 2002 Apr; 8(4):1271-6. PubMed ID: 11948142
[TBL] [Abstract][Full Text] [Related]
15. High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer.
Bouvet M; Spernyak J; Katz MH; Mazurchuk RV; Takimoto S; Bernacki R; Rustum YM; Moossa AR; Hoffman RM
Cancer Res; 2005 Nov; 65(21):9829-33. PubMed ID: 16267005
[TBL] [Abstract][Full Text] [Related]
16. Biological characteristics of fluorescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice.
Yang BW; Liang Y; Xia JL; Sun HC; Wang L; Zhang JB; Tang ZY; Liu KD; Chen J; Xue Q; Chen J; Gao DM; Wu WZ
Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1077-84. PubMed ID: 19047839
[TBL] [Abstract][Full Text] [Related]
17. The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model.
Scholz A; Wagner K; Welzel M; Remlinger F; Wiedenmann B; Siemeister G; Rosewicz S; Detjen KM
Gut; 2009 Feb; 58(2):261-70. PubMed ID: 18829975
[TBL] [Abstract][Full Text] [Related]
18. Determination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer model.
Mach CM; Mathew L; Mosley SA; Kurzrock R; Smith JA
Anticancer Res; 2009 Jun; 29(6):1895-9. PubMed ID: 19528445
[TBL] [Abstract][Full Text] [Related]
19. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Fujisawa T; Joshi B; Nakajima A; Puri RK
Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
[TBL] [Abstract][Full Text] [Related]
20. The novel hypoxic cell radiosensitizer, TX-1877 has antitumor activity through suppression of angiogenesis and inhibits liver metastasis on xenograft model of pancreatic cancer.
Miyake K; Shimada M; Nishioka M; Sugimoto K; Batmunkh E; Uto Y; Nagasawa H; Hori H
Cancer Lett; 2008 Dec; 272(2):325-35. PubMed ID: 18762366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
